Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
about
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys.Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatumEffect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice.Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans.Effects of repeated 3,4-methylenedioxymethamphetamine administration on neurotransmitter efflux and sensory-evoked discharge in the ventral posterior medial thalamus.Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profileBehavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboonsDiscriminative stimulus effects of 3,4-methylenedioxymethamphetamine and its enantiomers in mice: pharmacokinetic considerations.Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the ratNonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.Sleep loss and acute drug abuse can induce DNA damage in multiple organs of mice.Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users.
P2860
Q24619949-BDDCCE43-2E9E-49D8-9B3B-9D759597F73FQ30535782-08F700D1-A703-4459-AC92-77512E71FE95Q34035262-D2A44197-DDCA-4E39-B76F-D6DB79BFF1AEQ34051713-83A7AF4B-6054-4139-B192-18119EF8D828Q34243521-730E4E17-2FE0-4A89-92ED-F9E1798210C4Q35077922-288A631E-6497-4854-B961-A00905386DA2Q35079542-2605E2B2-FEA5-4BA2-9D20-5C55D2D7CBD7Q35176011-79632512-1AD9-4F6D-B91F-20E37AF29948Q35650765-185CC35C-679A-4771-B565-72CDA7AB327AQ36573258-B25CA432-6B2B-49DF-986B-3E560F64A10FQ36852604-8368847B-7133-40AA-A127-7EA9F21E7AE0Q37196303-F73CB9B7-C5BD-4C93-B65A-1CEE82D2EC27Q37415781-A35C77DC-40D2-4FAD-BE49-41AD40FBE604Q37422671-A5027070-3F48-47A4-B62A-529C4D9C410DQ46115355-E626A4CF-DE80-420C-AD2B-7B8E97804E80Q52298136-365A5058-845F-488C-8B06-8FA4075CB5FA
P2860
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Nonlinear pharmacokinetics of ...... er typical psychoactive doses.
@ast
Nonlinear pharmacokinetics of ...... er typical psychoactive doses.
@en
Nonlinear pharmacokinetics of ...... er typical psychoactive doses.
@nl
type
label
Nonlinear pharmacokinetics of ...... er typical psychoactive doses.
@ast
Nonlinear pharmacokinetics of ...... er typical psychoactive doses.
@en
Nonlinear pharmacokinetics of ...... er typical psychoactive doses.
@nl
prefLabel
Nonlinear pharmacokinetics of ...... er typical psychoactive doses.
@ast
Nonlinear pharmacokinetics of ...... er typical psychoactive doses.
@en
Nonlinear pharmacokinetics of ...... er typical psychoactive doses.
@nl
P2093
P356
P1476
Nonlinear pharmacokinetics of ...... ter typical psychoactive doses
@en
P2093
Frank T Peters
George A Ricaurte
Melanie Mueller
Una D McCann
P356
10.1124/JPET.108.141366
P407
P577
2008-06-30T00:00:00Z